Overview


According to FutureWise analysis the market for Radiotherapy in 2023 is US$ 6.64 billion, and is expected to reach US$ 10.04 billion by 2031 at a CAGR of 5.30%.

Improvements and further amendments in image-guided radiotherapy are propelling the market. The rising preference towards radiotherapy procedures for cancer treatment coupled with increasing usage of particle therapy for cancer diagnosis is spurring the market growth. Latest technological advancements in radiotherapy are expected to propel the market. Furthermore, rising incidences of cancer have expanded the market. According to the American Cancer Society, in 2020, there will be an estimated 1,762,450 new cancer cases diagnosed and 606,880 cancer deaths in the United States. The rise in research and development activities regarding cancer treatment launched by non-government and government organizations is expected to boost the market.

The market is classified into product type, type, application, end-user and region. Based on regions, North America dictates the market growth. Presence of prominent players and developed healthcare infrastructure is boosting the market in the region. Growing cases of cancer and favorable government policies are promoting adoption of radiotherapy, thus positively influencing the market. Asia-Pacific region is expected to be a lucrative region for manufacturers owing to a rapidly improving healthcare infrastructure and growing per capita income in emerging economies like China, Japan and India. In addition, favorable policies launched by the governments of these countries is expected to strengthen market position in the region.

  • Accuray Incorporated
  • C. R. Bard, Inc.
  • Elekta
  • Hitachi, LTD.
  • Iba (Ion Beam Applications Sa)
  • Isoray Medical, Inc.
  • Mevion Medical Systems, Inc.
  • Optivus Proton Therapy, Inc.
  • Panacea Medical Technologies Pvt. LTD.
  • P-Cure LTD.
  • Provision Healthcare, LLC.
  • Sumitomo Heavy Industries, LTD
  • Theragenics Corporation
  • Varian Medical Systems, Inc.
  • Viewray Inc.

(Note: The list of the major players will be updated with the latest market scenario and trends)

Varian Medical Systems in 2017, opened its centre in Jundiai, Brazil. The move will increase the access to advanced radiotherapy equipment and treatment across Brazil.
Varian Medical Systems launched an innovative treatment platform called Halcyon Treatment System. The system eases treatment delivery with increased speed and high-quality plans.
Mitsubishi Electric in 2017 decided to transfer its particle therapy systems to Hitachi.

By Product Type

  • External Beam Radiotherapy
    • Linear Accelerators (LINAC)
      • Conventional Linear Accelerators
      • Stereotactic Advanced Electron/Cobalt-60 Linear Accelerators
        • Gamma Knife
        • Cyberknife
        • Tomotherapy
    • Particle Therapy Systems
      • Cyclotrons
      • Synchrotrons
      • Synchrocyclotrons
    • Conventional Cobalt-60 Teletherapy Units
  • Internal Beam Radiotherapy/Brachytherapy
    • Seeds
    • Applicators
    • Afterloaders
    • Electronic Brachytherapy Products
  • Systemic Radiotherapy
    • Iobenguane (I-131)
    • Samarium-153
    • Rhenium-186
    • Other Systemic Radiotherapy Products

By Type

  • External Beam Radiotherapy
    • Image-Guided Radiotherapy (IMRT)
    • 3D Conformal Radiotherapy (3D CRT)
    • Intensity-Modulated Radiotherapy (IMRT)
      • Volumetric Arc Therapy (VMAT)
      • Tomotherapy
    • Stereotactic Therapy
    • Particle Therapy (Heavy-Ion and Proton Therapy)
  • Internal Beam Radiotherapy
    • Low-Dose-Rate (LDR) Brachytherapy
    • High-Dose-Rate (HDR) Brachytherapy
    • Pulsed-Dose-Rate (PDR) Brachytherapy
  • Systemic Radiotherapy
    • Intravenous Radiotherapy
    • Oral Radiotherapy
    • Instillation Radiotherapy

By Application

  • External Beam Radiation Therapy
    • Prostate Cancer
    • Breast Cancer
    • Lung Cancer
    • Head and Neck Cancer
    • Colorectal Cancer
    • Other Cancers
  • Internal Beam Radiotherapy/Brachytherapy
    • Prostate Cancer
    • Gynecological Cancer
    • Breast Cancer
    • Cervical Cancer
    • Penile Cancer
    • Other Cancers

By End User

  • Hospitals
  • Independent Radiotherapy Centers

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on radiotherapy the market by type, by product type, by application, by end-user and by region
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America and Middle East and Africa
  • To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions
  • Profiling of companies to evaluate their market shares, strategies, financial and core competencies

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Global Radiotherapy Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Radiotherapy Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Global Radiotherapy Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Global Radiotherapy Market, By Product Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. External Beam Radiotherapy
         1.1. Linear Accelerators (LINAC)
          1.1.1. Conventional Linear Accelerators
          1.1.2. Stereotactic Advanced Electron/Cobalt-60 Linear Accelerators
           1.1.2.1. Gamma Knife
           1.1.2.2. Cyberknife
           1.1.2.3. Tomotherapy
         1.2. Particle Therapy Systems
          1.2.1. Cyclotrons
          1.2.2. Synchrotrons
          1.2.3. Synchrocyclotrons
         1.3. Conventional Cobalt-60 Teletherapy Units
        2. Internal Beam Radiotherapy/Brachytherapy
         2.1. Seeds
         2.2. Applicators
         2.3. Afterloaders
         2.4. Electronic Brachytherapy Products
        3. Systemic Radiotherapy
         3.1. Iobenguane (I-131)
         3.2. Samarium-153
         3.3. Rhenium-186
         3.4. Other Systemic Radiotherapy Products

  • 8.   Global Radiotherapy Market, By Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. External Beam Radiotherapy
         1.1. Image-Guided Radiotherapy (IMRT)
         1.2. 3D Conformal Radiotherapy (3D CRT)
         1.3. Intensity-Modulated Radiotherapy (IMRT)
          1.3.1. Volumetric Arc Therapy (VMAT)
          1.3.2. Tomotherapy
         1.4. Stereotactic Therapy
         1.5. Particle Therapy (Heavy-Ion and Proton Therapy)
        2. Internal Beam Radiotherapy
         2.1. Low-Dose-Rate (LDR) Brachytherapy
         2.2. High-Dose-Rate (HDR) Brachytherapy
         2.3. Pulsed-Dose-Rate (PDR) Brachytherapy
        3. Systemic Radiotherapy
         3.1. Intravenous Radiotherapy
         3.2. Oral Radiotherapy
         3.3. Instillation Radiotherapy

  • 9.   Global Radiotherapy Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. External Beam Radiation Therapy
         1.1. Prostate Cancer
         1.2. Breast Cancer
         1.3. Lung Cancer
         1.4. Head and Neck Cancer
         1.5. Colorectal Cancer
         1.6. Other Cancers
        2. Internal Beam Radiotherapy/Brachytherapy
         2.1. Prostate Cancer
         2.2. Gynecological Cancer
         2.3. Breast Cancer
         2.4. Cervical Cancer
         2.5. Penile Cancer
         2.6. Other Cancers

  • 10.   Global Radiotherapy Market, By End User Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Hospitals
        2. Independent Radiotherapy Centers

  • 11.   North America Radiotherapy Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 12.   Latin America Radiotherapy Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 13.   Europe Radiotherapy Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 14.   Asia Pacific Radiotherapy Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 15.   Middle East and Africa Radiotherapy Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 16.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 17.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Accuray Incorporated
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. C. R. Bard, Inc.
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Elekta
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Hitachi, LTD.
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Iba (Ion Beam Applications Sa)
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Isoray Medical, Inc.
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Mevion Medical Systems, Inc.
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Optivus Proton Therapy, Inc.
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Panacea Medical Technologies Pvt. LTD.
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. P-Cure LTD.
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. Provision Healthcare, LLC.
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
        12. Sumitomo Heavy Industries, LTD
         12.1. Company Overview
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview
        13. Theragenics Corporation
         13.1. Company Overview
         13.2. Product Portfolio
         13.3. SWOT Analysis
         13.4. Financial Overview
         13.5. Strategic Overview
        14. Varian Medical Systems, Inc.
         14.1. Company Overview
         14.2. Product Portfolio
         14.3. SWOT Analysis
         14.4. Financial Overview
         14.5. Strategic Overview
        15. Viewray Inc.
         15.1. Company Overview
         15.2. Product Portfolio
         15.3. SWOT Analysis
         15.4. Financial Overview
         15.5. Strategic Overview

  • 18.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 19.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients